deCode, MediChem deal

DCGN will acquire MCLS for 8.3 million shares valued at $76.8

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE